Effect of Short Term Adrenal Suppression on Androgen Overproduction in Overweight Girls With Androgen Excess (CBS003)
The CBS003 trial, sponsored by the University of Virginia, aimed to evaluate the effects of short-term hydrocortisone on androgen overproduction in overweight girls with hyperandrogenemia. The study was withdrawn prior to enrollment, indicating potential challenges in feasibility or strategic alignment. The market for treatments addressing hyperandrogenemia, particularly in the context of obesity and conditions like Polycystic Ovary Syndrome (PCOS), remains significant, with a growing demand for effective interventions. Competitors in this space may include hormonal therapies and lifestyle interventions, but the withdrawal of this trial may raise concerns regarding the viability of hydrocortisone as a treatment option. Further diligence is warranted to assess ongoing research and alternative therapeutic approaches.
Indication: Hyperandrogenemia
Modality: small molecule
Target: Adrenal gland function and androgen production regulation
Sponsor: University of Virginia
Source URL: ClinicalTrials.gov
Source updated: Detailed source ingestion pending
Ingested: Jul 11, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Adrenal gland function and androgen production regulation
View original source fields
Condition raw: Hyperandrogenemia, Obesity, Polycystic Ovary Syndrome
Condition normalized: Hyperandrogenemia, Obesity, Polycystic Ovary Syndrome
Modality raw: small molecule
Modality normalized: small molecule
Target raw: Adrenal gland function and androgen production regulation
Target normalized: Adrenal gland function and androgen production regulation